The antitumor antibiotic rebeccamycin—challenges and advanced approaches in production processes
- 201 Downloads
Rebeccamycin is an antibiotic and antitumor substance isolated from the filamentous bacterium Lentzea aerocolonigenes. After its discovery, investigations of rebeccamycin focused on elucidating its structure, biological activity, and biosynthetic pathway. For potential medical application, a sufficient drug supply has to be ensured, meaning that the production process of rebeccamycin plays a major role. In addition to the natural production of rebeccamycin in L. aerocolonigenes, where the complex cell morphology is an important factor for a sufficient production, rebeccamycin can also be heterologously produced or chemically synthesized. Each of these production processes has its own challenges, and first approaches to production often lead to low final product concentrations, which is why process optimizations are performed. This review provides an overview of the production of rebeccamycin and the different approaches used for rebeccamycin formation including process optimizations.
KeywordsLentzea aerocolonigenes Rebeccamycin Morphology engineering Process optimization
This study was funded by the German Research Foundation (DFG) in the Priority Programme 1934 DiSPBiotech—Dispersity, structural and phase modifications of proteins and biological agglomerates in biotechnological processes.
Compliance with ethical standards
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare that they have no conflict of interest.
- Casini A, Chang FY, Eluere R, King AM, Young EM, Dudley QM, Karim A, Pratt K, Bristol C, Forget A, Ghodasara A, Warden-Rothman R, Gan R, Cristofaro A, Borujeni AE, Ryu MH, Li J, Kwon YC, Wang H, Tatsis E, Rodriguez-Lopez C, O’Connor S, Medema MH, Fischbach MA, Jewett MC, Voigt C, Gordon DB (2018) A pressure test to make 10 molecules in 90 days: external evaluation of methods to engineer biology. J Am Chem Soc 140:4302–4316CrossRefGoogle Scholar
- Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA (2000) Practical streptomyces genetics. The John Innes Foundation, NorwichGoogle Scholar
- Lagmay JP, Krailo MD, Dang H, Kim A, Hawkins DS, Beaty O, Widemann BC, Zwerdling T, Bomgaars L, Langevin A-M, Grier HE, Weigel B, Blaney SM, Gorlick R, Janeway KA (2016) Outcome of patients with recurrent osteosarcoma enrolled in seven phase II trials through children’s cancer group, pediatric oncology group, and children’s oncology group: learning from the past to move forward. J Clin Oncol 34:3031–3038CrossRefGoogle Scholar
- Nettleton DE, Jr., Bush JA, Bradner WT, Doyle TW (1985) Process for producing rebeccamycin. US Patent:Patent No 4,552,842Google Scholar
- Pridham TG (1970) New names and new combinations in the order Actinomycetales Buchanan 1917. Technical bulletin 1424. United States Department of Agriculture, US Government Printing Service, Washington DCGoogle Scholar
- Walisko R, Moench-Tegeder J, Blotenberg J, Wucherpfennig T, Krull R (2015) The taming of the shrew—controlling the morphology of filamentous eukaryotic and prokaryotic microorganisms. Adv Biochem Eng Biotechnol 149:1–27Google Scholar